CytomX Therapeutics Inc (NASDAQ:CTMX) currently has a daily average trading volume of 5.13M but it saw 2798149 shares traded in last market. With a market cap of 321.39M USD, the company’s current market price of $2.04 came falling about -0.97 while comparing to the previous closing price of $2.06. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.55 and as low as $0.40.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which upgraded the stock as “Buy” in its note to investors issued on May 15, 2025, recommending a price target of $5 for it. Piper Sandler also issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $2.25 and $3.50.
Over the week, CTMX’s stock price is moving -14.29% down while it is 177.14% when we observe its performance for the past one month. Year-to-date it is 98.06% up and over the past year, the stock is showing an upside performance of 7.94%.
Currently, CytomX Therapeutics Inc’s total number of outstanding shares is 157.54M with 0.59% of that held by the insiders while 51.06% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 149.09%. It has a price to earnings ratio (P/E ratio) of 4.11. Stock’s beta reads 1.65. Stock has a price to book (P/B) ratio of 6.57 while price to sale or P/S ratio amounts to 2.18. Its return on asset (ROA) is 29.38% on average.
